|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 4:409-418, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.
,


From the
Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702-1201
¶ Department of Neurological Surgery, University of Washington School of Medicine, Seattle, WA 98195
Proteomics has brought with it the hope of identifying novel biomarkers for diseases such as cancer. This hope is built on the ability of proteomic technologies, such as mass spectrometry (MS), to identify hundreds of proteins in complex biofluids such as plasma and serum. There are many factors that make this research very challenging beginning with the lack of standardization of sample collection and continuing through the entire analytical process. Fortunately the advances made in the characterization of biofluids using proteomic techniques have been rapid and suggest that these mainly discovery driven approaches will lead to the development of highly specific platforms for diagnosing diseases and monitoring responses to different treatments in the near future.
To whom correspondence should be addressed: SAIC-Frederick, Inc., National Cancer Institute at Frederick, P.O. Box B, Bldg. 469, Rm. 160, Frederick, MD 21702. Tel.: 301-846-7286; Fax: 301-846-6037; E-mail:veenstra{at}ncifcrf.gov
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. V. G. Edwards, M. Y. White, and S. J. Cordwell The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery Mol. Cell. Proteomics, October 1, 2008; 7(10): 1824 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Martins de Souza, B. M. Oliveira, E. Castro-Dias, F. V. Winck, R. S. O. Horiuchi, P. A. Baldasso, H. T. Caetano, N. K. D. Pires, S. Marangoni, and J. C. Novello The untiring search for the most complete proteome representation: reviewing the methods Brief Funct Genomic Proteomic, July 1, 2008; 7(4): 312 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Seam, D. A. Gonzales, S. J. Kern, G. L. Hortin, G. T. Hoehn, and A. F. Suffredini Quality Control of Serum Albumin Depletion for Proteomic Analysis Clin. Chem., November 1, 2007; 53(11): 1915 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kita, Y. Miura, J.-i. Furukawa, M. Nakano, Y. Shinohara, M. Ohno, A. Takimoto, and S.-I. Nishimura Quantitative Glycomics of Human Whole Serum Glycoproteins Based on the Standardized Protocol for Liberating N-Glycans Mol. Cell. Proteomics, August 1, 2007; 6(8): 1437 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Azad, N. Rasool, C. M. Annunziata, L. Minasian, G. Whiteley, and E. C. Kohn Proteomics in Clinical Trials and Practice: Present Uses and Future Promise Mol. Cell. Proteomics, October 1, 2006; 5(10): 1819 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1727 - 1744. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |